Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens.
Clostridium difficile is a major cause of antibiotic-associated diarrheal disease in many parts of the world. In recent years, distinct genetic variants of C. difficile that cause severe disease and persist within health care settings have emerged. Highly resistant and infectious C. difficile spores are proposed to be the main vectors of environmental persistence and host transmission, so methods to accurately monitor spores and their inactivation are urgently needed. Here we describe simple quantitative methods, based on purified C. difficile spores and a murine transmission model, for evaluating health care disinfection regimens. We demonstrate that disinfectants that contain strong oxidizing active ingredients, such as hydrogen peroxide, are very effective in inactivating pure spores and blocking spore-mediated transmission. Complete inactivation of 10⁶ pure C. difficile spores on indicator strips, a six-log reduction, and a standard measure of stringent disinfection regimens require at least 5 min of exposure to hydrogen peroxide vapor (HPV; 400 ppm). In contrast, a 1-min treatment with HPV was required to disinfect an environment that was heavily contaminated with C. difficile spores (17 to 29 spores/cm²) and block host transmission. Thus, pure C. difficile spores facilitate practical methods for evaluating the efficacy of C. difficile spore disinfection regimens and bringing scientific acumen to C. difficile infection control.
Lawley
Trevor D
TD
Microbial Pathogenesis Laboratory, Wellcome Trust, Hinxton, Cambridgeshire CB10 1SA, United Kingdom. tl2@sanger.ac.uk
Clare
Simon
S
Deakin
Laura J
LJ
Goulding
David
D
Yen
Jennifer L
JL
Raisen
Claire
C
Brandt
Cordelia
C
Lovell
Jon
J
Cooke
Fiona
F
Clark
Taane G
TG
Dougan
Gordon
G
D000818:Animals; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000635:transmission; D004195:Disease Models, Animal; D004203:Disinfection / Q000379:methods*; D004783:Environmental Microbiology; D006268:Health Facilities; D017053:Infection Control / Q000379:methods*; D051379:Mice; D011786:Quality Control; D013171:Spores, Bacterial / Q000302:isolation & purification*
J Hosp Infect. 2008 Oct;70(2):136-41
18694613
Mol Microbiol. 2009 Mar;71(5):1308-22
19183279
N Engl J Med. 2005 Dec 8;353(23):2442-9
16322602
Infect Control Hosp Epidemiol. 2010 Jan;31(1):21-7
19929371
Infect Control Hosp Epidemiol. 2008 Aug;29(8):723-9
18636950
Infect Control Hosp Epidemiol. 2009 Jun;30(6):507-14
19379098
Infect Control Hosp Epidemiol. 2007 Aug;28(8):920-5
17620238
Infect Immun. 2009 Sep;77(9):3661-9
19564382
J Clin Microbiol. 1982 Mar;15(3):443-6
7076817
J Antimicrob Chemother. 1998 May;41 Suppl C:13-9
9630370
Infect Control Hosp Epidemiol. 2009 Oct;30(10):939-44
19715426
J Hosp Infect. 2003 Jun;54(2):109-14
12818583
J Clin Microbiol. 2009 Jan;47(1):205-7
18971364
Clin Infect Dis. 2000 Oct;31(4):995-1000
11049782
Comput Biol Med. 1984;14(4):377-84
6548942
Nat Genet. 2006 Jul;38(7):779-86
16804543
J Bacteriol. 2008 Apr;190(7):2505-12
18245298
J Exp Med. 2006 Jan 23;203(1):21-6
16390940
FEMS Microbiol Rev. 2008 May;32(3):541-55
18397287
Clin Infect Dis. 2007 Oct 15;45(8):992-8
17879913
Clin Microbiol Infect. 2007 Mar;13(3):298-304
17391385
Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S43-9
18177221
Nat Rev Microbiol. 2006 Apr;4(4):307-12
16518420
Genome Biol. 2009;10(9):R102
19781061
Clin Microbiol Infect. 2008 May;14 Suppl 5:2-20
18412710
J Hosp Infect. 2009 Dec;73(4):378-85
19726106
PDA J Pharm Sci Technol. 1998 Sep-Oct;52(5):228-31
9846070
Br J Biomed Sci. 2008;65(1):39-44
18476496
N Engl J Med. 2005 Dec 8;353(23):2433-41
16322603
Ann Intern Med. 2006 Nov 21;145(10):758-64
17116920
Infect Immun. 2008 Jan;76(1):403-16
17967858
Infect Control Hosp Epidemiol. 2007 Feb;28(2):205-7
17265404
J Bacteriol. 2009 Sep;191(17):5377-86
19542279
J Hosp Infect. 2007 Jun;65 Suppl 2:50-4
17540242
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7527-32
20368420
Clin Microbiol Rev. 1999 Jan;12(1):147-79
9880479